Brief: Stayble Therapeutics Enters Into LoI On Potential Strategic Collaboration, Financing
07/05/2026 08:54
May 7 (Reuters) - Stayble Therapeutics AB STABL.ST: SAID ON WEDNESDAY STAYBLE THERAPEUTICS HAS ENTERED INTO LETTER OF INTENT WITH INTERNATIONAL STRATEGIC INVESTOR FOR CONTINUED FINANCING OF BUSINESS INVESTOR INTENDS TO CONTRIBUTE TO SECURING THE COMPANY'S INITIAL SHORT-TERM CAPITAL NEEDS INVESTOR INTENDS TO SUBSTANTIALLY PARTICIPATE IN FINANCING OF THE COMPANY'S PLANNED PHASE 2B DEVELOPMENT Source text for Workspace: nWkr53PVfb Further company coverage: STABL.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Stayble Therapeutics AB
See all newsBrief: Stayble Therapeutics Delisted From Nasdaq First North Growth Market
Brief: Stayble Therapeutics To Apply For Bankruptcy
Brief: Stayble Therapeutics Q1 EBIT Loss Narrows To SEK 6.9 Mln
Brief: Stayble Therapeutics Enters Into LoI On Potential Strategic Collaboration, Financing
Brief: Stayble Therapeutics Q4 Oper Loss To SEK 1.5 Mln